Invest in

Biotech Breakthroughs

4.9%
12.2%
0.0%

Feeling Better About Biotech

The next big cure for a complex, scary disease is unlikely to come from old-school pharma. It’s likely coming from biotech. Scientists, investors, and patients are all banking on the $93 billion biotech industry.[1] It’s outpaced Big Pharma in finding treatments for cancer, AIDS, multiple sclerosis, and other diseases. The FDA approved 43 drugs in 2012, a 20% jump from the previous year.[4] Big Pharma has responded by snapping up promising biotech and smaller pharmaceutical companies, at lofty valuations, with premiums for several public companies in excess of 50%.[2] In fact, 2013 was a big year for the biotech industry, with $29B in M&A deals through the 1st half of 2013.[3] This motif includes only biotech companies with at least two years of cash flow to help screen out companies at greater risk of losing money. See more
4.9%
12.2%
0.0%
Invest in Thematic Portfolios
Create your own customizable basket of up to 30 stocks or ETFs for just $9.95.
Motif Index 1 YR Return
Biotech Breakthroughs Benchmark
Open a Motif account to view and trade this basket of stocks for just $9.95:
Weight Segment & Stocks Symbol 1 MO / 1 YR Return
31.7% Cancer 3.9%
18.1% Amgen Inc. AMGN 18.6%
12.3% Celgene Corporation CELG 15.3%
1.3% 8xxxxxx 8xxxxxxx 8xxx 8xxx 88.8%
20.2% Research & Diagnostics 21.5%
8.5% 8xxxx 8xxxxxxx 8xx 8xx --
4.1% 8xxxxxxx 8xxx 8xxx 88.8%
3.3% 8xxxxxx 8xxxx 8xxxxxxxxxxx 8xxxxxxxxxxxx 8xx 88.8%
3.2% 8xxxxxxxxx 8xxx 8xxx 88.8%
1.0% 8xxxxxx 8xxxxxxxxxx 8xxx 88.8%
17.5% Other Diseases 12.7%
5.6% 8xxxxxxxx 8xxxxxxxxxxxxxx 8xxx 8xxx 88.8%
4.9% 8xxxxx 8xxxxxxxxxxxxxx 8xxxxxxxxxxx 8xxx 88.8%
4.4% 8xxxxxx 8xxxxxxxxxxxxxx 8xxx 8xxx 88.8%
1.8% 8xxxxx 8xxxxxxxxxxx 8xxxxxxxxxx 8xxx 88.8%
0.8% 8xxxxxxx 8xxxxxxxxxx 8xxx 88.8%
16.9% Autoimmune Disorders 1.8%
9.5% 8xxxxx 8xxx 8xxx 88.8%
3.0% 8xxxxx 8xxxxxxxxxx 8xxx 88.8%
2.9% 8xxxxxxx 8xxxxxxxxxxxxx 8xxx 8xxx 88.8%
1.5% 8xxxxxxxx 8x 8xxxx 8xx 8xxx 88.8%
12.9% Infectious Diseases 1.4%
12.9% Gilead Sciences Inc. GILD 1.4%
0.9% Cardiovascular 26.6%
0.9% 8xxxx 8xxxxxxxxxxxxxx 8xx 8xxx 88.8%

Quotes delayed 15 mins. Currently Nov 19, 2017 10:51:29 PM. Fields are marked with -- when data is unavailable.